The MIRACLE Project
MIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.
Plus de détails Plus de détailsMIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.
Plus de détails Plus de détailsMedical Application of Virtual and Augmented Reality Tools. With the Virtual Reality tool Specto, doctors can interact in a three-dimensional space with the patient data prior to surgery.
Plus de détailsInhale, then exhale. This simple act could now save lives. A technology developed in part at EPFL can quickly identify the presence of a head and neck cancer, such as of the throat or mouth by analysing people's breath. The new device, equipped with extremely sensitive sensors, has been tested on patients and operates with a computer or even a mobile phone.
Plus de détailsThe results of the research and development activities in chemical, pharmaceutical and many other areas often depend on the correctly identified structure of the analyzed sample. X-Ray Powder Diffraction (XRPD) is considered the gold standard method for identifying and quantifying crystalline solid forms and provides the industry with crucial data.
Plus de détailsThe exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical and pharmaceutical research. Using state-of-the-art technologies at the Paul Scherrer Institute (PSI), the company Crystallise! has achieved unprecedented results in absolute configuration determination of a small single crystal of a light atom compound.
Plus de détailsModern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. Obtaining a polymorph portfolio of a compound is a demanding process. With its advantages, electron diffraction represents one of the most promising fields of research for unlocking new possibilities in structure-based drug discovery.
Plus de détailsMembrane protein drug targets represent a significant challenge for high-resolution three-dimensional structure determination limiting the discovery and development of novel medicines. leadXpro AG, a company at PARK INNOVAARE, successfully tackles the membrane protein structure identification challenge to advance the drug discovery process and bring better drugs to the market.
Plus de détailsStoring solar energy as hydrogen is a promising way for developing comprehensive renewable energy systems. Building on a unique idea, EPFL scientists have now developed a simple, unconventional method to fabricate high-quality, efficient solar panels for direct solar hydrogen production with low cost.
Plus de détailsEPFL scientists have developed a method that improves the accuracy of DNA sequencing up to a thousand times. The method, which uses nanopores to read individual nucleotides, paves the way for better – and cheaper – DNA sequencing. Reading the exact make-up of genes, scientists can detect mutations, or even identify different organisms.
Plus de détailsIn 2016 a new organisation, Switzerland Innovation – the Swiss innovation park, started operating in Switzerland. It is a platform that unites five innovation...
Plus de détailsDie Parks von Switzerland Innovation haben vor anderthalb Jahren eröffnet. Heute sind dort rund 80 forschungsorientierte Unternehmen angesiedelt. Artikel...
Plus de détailsThe most innovative country in the world must constantly launch new initiatives to attract R&D activities if that lead is to be maintained, and Switzerland...
Plus de détails